Back to News
Market Impact: 0.4
STE Stock Up on Q2 Earnings & Revenue Beat, '27 EPS View Up
Source: zacks.com
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
STERIS beat Q2 fiscal 2027 earnings and revenue estimates, citing strong segment growth and margin gains. The company raised its full-year adjusted EPS outlook; the article provides no figures for the beat or revised guidance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.55
Ticker Sentiment
STE0.80
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook